- Home
- GPUS vs XBIO Comparison
GPUS vs XBIO Comparison
Compare GPUS & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- XBIO
- Stock Information
- Founded
- GPUS 1969
- XBIO N/A
- Country
- GPUS United States
- XBIO United States
- Employees
- GPUS N/A
- XBIO N/A
- Industry
- GPUS
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GPUS
- XBIO Health Care
- Exchange
- GPUS NYSE
- XBIO Nasdaq
- Market Cap
- GPUS 4.8M
- XBIO 4.2M
- IPO Year
- GPUS 1996
- XBIO N/A
- Fundamental
- Price
- GPUS $1.34
- XBIO $4.12
- Analyst Decision
- GPUS
- XBIO Hold
- Analyst Count
- GPUS 0
- XBIO 1
- Target Price
- GPUS N/A
- XBIO N/A
- AVG Volume (30 Days)
- GPUS 8.9M
- XBIO 185.5K
- Earning Date
- GPUS 08-15-2025
- XBIO 08-12-2025
- Dividend Yield
- GPUS N/A
- XBIO N/A
- EPS Growth
- GPUS N/A
- XBIO N/A
- EPS
- GPUS N/A
- XBIO N/A
- Revenue
- GPUS $93,318,000.00
- XBIO $2,582,728.00
- Revenue This Year
- GPUS N/A
- XBIO $14.23
- Revenue Next Year
- GPUS N/A
- XBIO $7.14
- P/E Ratio
- GPUS N/A
- XBIO N/A
- Revenue Growth
- GPUS N/A
- XBIO 5.63
- 52 Week Low
- GPUS $1.23
- XBIO $2.20
- 52 Week High
- GPUS $11.73
- XBIO $5.27
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- XBIO 61.86
- Support Level
- GPUS N/A
- XBIO $3.44
- Resistance Level
- GPUS N/A
- XBIO $4.00
- Average True Range (ATR)
- GPUS 0.00
- XBIO 0.54
- MACD
- GPUS 0.00
- XBIO 0.05
- Stochastic Oscillator
- GPUS 0.00
- XBIO 50.70
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has six reportable segments: Energy and Infrastructure; Technology and Finance; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Global Real Estate Equities, Inc.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.